Safety and preliminary efficacy in patients with relapsed/refractory mantle cell lymphoma receiving lisocabtagene maraleucel in TRANSCEND NHL 001 Meeting Abstract
| Authors: | Palomba, M. L.; Gordon, L. I.; Siddiqi, T.; Abramson, J. S.; Kamdar, M.; Lunning, M. A.; Maloney, D. G.; Andreadis, C.; Arnason, J. E.; Ghosh, N.; Mehta, A.; Solomon, S. R.; Farazi, T.; Garcia, J.; Dehner, C.; Ogasawara, K.; Gao, J.; Wang, M. |
| Abstract Title: | Safety and preliminary efficacy in patients with relapsed/refractory mantle cell lymphoma receiving lisocabtagene maraleucel in TRANSCEND NHL 001 |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205605036 |
| DOI: | 10.1182/blood-2020-136158 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10 -- Source: Wos |
